Zealand inks up to $1.3B deal for AI-designed obesity treatments
Zealand Pharma said Tuesday it will develop new protein-based treatments for obesity and other metabolic diseases with the help of Generate Biomedicines’ AI technology. The Danish drugmaker is spending $30 million upfront for two initial ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.